The hidden cost of MSK absence in modern UK workplaces
Musculoskeletal disorders are the largest cause of work-related ill-health in the UK after stress. The real cost sits on three lines of the P&L — and most leadership teams only see one.
In clinical practice across NHS musculoskeletal services, the same pattern shows up year after year: by the time someone is sitting in front of a physiotherapist, the problem has usually been brewing for months, and the employer has already absorbed most of the cost without realising it.
The Health and Safety Executive's most recent figures put MSK disorders at 7.8 million working days lost in 2023/24 — the single biggest cause of work-related ill-health after stress, depression and anxiety. For a 200-person workforce on a £50k average salary, that benchmark translates to roughly £124,000 a year in pure absence cost before you touch productivity, agency cover or turnover.
Why the line item on the absence report is the smallest of the three
When finance teams look at MSK, they usually see the absence number. That's the visible cost. The two larger costs are harder to attribute:
- Presenteeism. Employees turn up but work at 60–70% capacity because of pain. CIPD and Deloitte have both modelled this as 2–3x the cost of absence itself.
- Turnover. People leave roles where the physical demand outpaces the support. Replacement cost is typically 6–9 months of salary once you factor recruitment, lost productivity and onboarding.
A single avoidable MSK exit on a £50k role is roughly £30k of replacement cost. One a quarter wipes out most wellbeing budgets.
What actually moves the number
In the programmes I've helped design, three things consistently shift the absence and presenteeism curves inside 90 days:
- On-site triage within 48 hours of symptom onset. Early intervention by a senior MSK physiotherapist resolves the majority of mechanical complaints in 1–3 sessions. The same complaint left for 6 weeks becomes a 6-month chronic issue.
- Workstation and task assessment, not generic ergonomic training. Group sessions teach awareness; one-to-one assessments change behaviour for the person actually at risk.
- A short, measurable strength block for the at-risk cohort. 8 weeks of 2x weekly loaded exercise has the strongest evidence base of any MSK intervention.
Notice what isn't on that list: yoga apps, posture reminders, generic webinars. They are not bad, but they don't move the absence number.
How to size the opportunity for your organisation
A realistic, conservative model for a 200-person UK workforce looks like this:
- Annual MSK absence cost (HSE benchmark): ~£124,000
- Presenteeism cost at 1.5x absence: ~£186,000
- Avoided MSK-driven turnover (1 exit/year): ~£30,000
A well-run on-site programme typically reduces the absence figure by 30–50% within the first year, with presenteeism following 6–12 months behind. The maths becomes obvious very quickly.
The organisations that act on MSK now are the ones whose finance directors have done this calculation. The ones that wait usually do so because no one has put the three numbers on the same page.
Craig Slattery is a senior NHS musculoskeletal physiotherapist and Director of Clinical Practice at Corpus Health.
Want this in your workplace?
Book a 30-minute consultation with our clinical team to scope a programme for your people.
Book a consultation